Emily Marine Leproust
Independent DirectorDr. Emily Marine Leproust, Ph.D., is Director of GeneDx, Inc. from July 2021. Dr. Leproust was Director of Atlas Data Storage, Inc. since May 2025. Dr. Leproust serves as Independent Director at CM Life Sciences, Inc. since September 2, 2020. She serves as an Independent Director at GeneDx Holdings Corp. (formerly known as Sema4 Holdings Corp.) (formerly known as Mount Sinai Genomics, Inc.) since July 2021. She co-founded Twist Bioscience Corporation in 2013 and has been its Chief Executive Officer and Director since April 2013 and served as its President. She is also Board Chair at Twist Bioscience Corporation since October 2018. She architected the successful SureSelect product line which lowered the cost of sequencing and elucidated dozens of mendelian diseases and she developed Agilents Oligo Library Synthesis technology, where she initiated and led product and business development activities for the team as well as co-led marketing and sales efforts associated with the product line. Dr. Leproust designed and executed multiple experimental synthesis platforms to streamline manufacturing and fabrication. Dr. Leproust has co-authored over 34 peer-reviewed papers, many on synthetic DNA and has extensive marketing, management and business development experience. Prior to Twist Bioscience, she was Director of Applications and Chemistry R&D Genomics at Agilent Technologies from February 2009 to April 2013, where she built and led the fastest growing product line, resulting in more than 100 million in revenues and more than 300 customer publications. Prior to Agilent, she worked with Dr. X. Gau at the University of Texas developing DNA and RNA parallel synthesis processes on solid support, a project developed commercially by Xeotron Corporation. She serves on the Board of Directors of the Nuclear Threat Institute. She earned her Ph.D. in organic chemistry from the University of Houston and her M.Sc. in industrial chemistry from the Lyon School of Industrial Chemistry in France.
Positions
- Company NameGeneDx Holdings Corp.Stock CodeWGSPositionIndependent DirectorColleagues
- KAKatherine A. StuelandCEO & Director
- KAKeith Arlyn MeisterIndependent Chairman of the Board
- KFKevin FeeleyChief Financial Officer
- BMBryan M. DechairoChief Technology & Innovation Officer
- MAMark A. GardnerPresident
- SVSabrina V. DunbarDirector of Investor Relations & Communications
- JRJoshua RuchIndependent Director
- EMEmily Marine LeproustIndependent Director
- RCRichard C. PfennigerIndependent Director
- Company NameTwist Bioscience CorporationStock CodeTWSTPositionCo-Founder, Board Chair & CEOColleagues
- PJPatrick John FinnPresident & COO
- ALAdam LaponisChief Financial Officer
- DCDennis ChoChief Legal Officer & Corporate Secretary
- PGPaula GreenSenior Vice President of Human Resources
- RBRobert B. ChessLead Independent Director
- JJJan JohannessenIndependent Director
- MAMelissa A. StarovasnikIndependent Director
- KLKeith L. CrandellIndependent Director
